2000•Zhonghua xiaohua zazhiRequires access

Sulindac inhibits proliferation of HT-29 colon adenocarcinoma cells: effects on cell cycle and apoptosis

Yuquan Wei

Open publisher page 1 citations

Abstract

Objective To investigate the effect of sulindac on the proliferation of the HT 29 cells and its antineoplastic mechanisms. Methods MTT colorimetric assay was used to examine the effect of sulindac on the proliferation of the HT 29 cells; flow cytometry was used for the cell cycle distribution; flow cytometry, transmission electron microscopy and DNA electrophoresis were used to determine whether or not sulindac induces cell apoptosis. Results Sulindac inhibited the cells proliferation, increased the proportion of cells in the G 0/G 1 phase, decreased the proportion of cells in the S phase and induced apoptosis of the HT 29 cell line. All the effects were in a time and dose dependent manner. Conclusion Colon adenocarcinoma HT 29 cell line can be inhibited by sulindac and the antitumor mechanism may be related to changing cell cycle distribution and inducing cell apoptosis.

About this research paper

What this paper is about

Objective To investigate the effect of sulindac on the proliferation of the HT 29 cells and its antineoplastic mechanisms. Methods MTT colorimetric assay was used to examine the effect of sulindac on the proliferation of the HT 29 cells; flow cytometry was used for the cell cycle distribution; flow cytometry, transmission electron microscopy and DNA electrophoresis were used to determine whether or not sulindac induces cell apoptosis. Results Sulindac inhibited the cells proliferation, increased the proportion of cells in the G 0/G 1 phase, decreased the proportion of cells in the S phase and induced apoptosis of the HT 29 cell line. All the effects were in a time and dose dependent manner. Conclusion Colon adenocarcinoma HT 29 cell line can be inhibited by sulindac and the antitumor mechanism may be related to changing cell cycle distribution and inducing cell apoptosis.

Why it matters

OpenAlex reports 1 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the effect of sulindac on the proliferation of the HT 29 cells and its antineoplastic mechanisms. Methods MTT colorimetric assay was used to examine the effect of sulindac on the proliferation of the HT 29 cells; flow cytometry was used for the cell cycle distribution; flow cytometry, transmission electron microscopy and DNA electrophoresis were used to determine whether or not sulindac induces cell apoptosis. Results Sulindac inhibited the cells proliferation, increased the proportion of cells in the G 0/G 1 phase, decreased the proportion of cells in the S phase and induced apoptosis of the HT 29 cell line. All the effects were in a time and dose dependent manner. Conclusion Colon adenocarcinoma HT 29 cell line can be inhibited by sulindac and the antitumor mechanism may be related to changing cell cycle distribution and inducing cell apoptosis.

Key concepts: Sulindac, Flow cytometry, Apoptosis, Cell cycle, Cell growth, Cell culture, Chemistry, Cell

Related papers

Back to paper searchBrowse research topicsOriginal source
Sulindac inhibits proliferation of HT-29 colon adenocarcinoma cells: effects on cell cycle and apoptosis — Research Paper | ScholarLens